Day: December 11, 2020

THC Therapeutics, Inc. (THCT), a forward-thinking publicly traded technology company whose mission statement is “Better Health through the Science of Nature”, today announced that as part of its evolving business and drive to increase shareholder value, it has implemented an executive hire and expanded its Board of DirectorsLAS VEGAS, Dec. 11, 2020 (GLOBE NEWSWIRE) — Mr. Parker Mitchell will assume the position of Chief Executive Officer and join the Board of Directors of THC Therapeutics immediately. Mr. Mitchell is an alumnus of The State University of New York at Buffalo and has been working with public companies for the better part of the last decade. Over the last five years, Mr. Mitchell has helped publicly traded companies by putting their company’s story and opportunities in front of the investing public. Mr....

Company provides machine vision solutions for modernization and expansion of parking services at one of the world’s busiest airportsCompany’s VRS technology already installed in over 30 international airports worldwide, including JFK, LaGuardia, Newark, Atlanta, Dallas Fort Worth, Dulles and many others in the U.S.SALT LAKE CITY, Dec. 11, 2020 (GLOBE NEWSWIRE) — OMNIQ Corp. (OTCQB: OMQS) (“OMNIQ” or “the Company”), a provider of Supply Chain and Artificial Intelligence (AI)-based solutions, today announced that the Company has received an order from HUB Parking Technology USA, Inc. (“HUB”) to provide vehicle recognition systems (VRS) technology for automated smart parking services at Los Angeles International Airport (LAX).HUB is integrating the smart parking project, which is part of a broader, multi-year and multibillion-dollar...

TORONTO, Dec. 11, 2020 (GLOBE NEWSWIRE) — Cardinal Resources Limited (ASX / TSX: CDV) (“Cardinal” or “the Company”) refers to the fifth supplementary bidder’s statement from Nord Gold SE (Nordgold) announced on the ASX Market Announcements Platform this morning in respect of its unconditional on‐market takeover bid for Cardinal.Cardinal notes that Nordgold has increased the Offer Price in respect of its on‐market takeover bid from A$1.00 to A$1.05 cash per share (Revised Nordgold Takeover Bid).Cardinal also notes that the offer price of the unconditional off‐market takeover bid made by Shandong Gold Mining (HongKong) Co., Ltd. (Shandong Gold) is also A$1.05 cash per share.In this regard, Cardinal notes that it has obligations under the Bid Implementation Agreement (as varied) with Shandong Gold and Shandong Gold Mining Co., Ltd...

SALT LAKE CITY, Dec. 11, 2020 (GLOBE NEWSWIRE) — In a spotlight poster discussion at the 2020 San Antonio Breast Cancer Symposium (SABCS), Myriad Genetics (NASDAQ: MYGN), a global leader in molecular diagnostics and precision medicine, today presented a new study that shows how its myRisk® Hereditary Cancer and riskScore® tests can better inform individualized clinical screening and prevention strategies for women at risk of developing breast cancer. The new Myriad study highlights how riskScore, a proprietary tool used to evaluate a woman’s risk of developing breast cancer, can accurately provide breast cancer risk information into a personalized assessment model for women carrying a pathogenic variant (PV) in the ATM gene. “This new study will enable a highly personalized risk calculation for patients who carry mutations in the...

LOS ANGELES, Dec. 11, 2020 (GLOBE NEWSWIRE) — Corida Corporation today announced that (OTCM: CORG) it has retained PCAOB registered accounting firm, BF Borgers CPA, PC to conduct an audit of its Consolidated Financial Statements for the fiscal years ending December 31, 2019 and 2020.Upon completion of the audit, the Company intends to become a fully reporting company with the Securities and Exchange Commission. Additionally, the Company plans to seek a listing on an exchange.The company anticipates that the audits and a filing will be completed during the first quarter of 2021.Cordia is developing virtual restaurants and ghost kitchen opportunities with recognized brands and celebrities. It expects to offer its celebrity and brand menus in approximately 1000 restaurants and ghost kitchens over the next twelve months. Restaurants...

GAITHERSBURG, Md., Dec. 11, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Scott Harris, Chief Medical Officer of Altimmune will give an oral presentation on ALT-801, the Company’s novel GLP-1/Glucagon dual receptor agonist in development for the treatment of non-alcoholic steatohepatitis (NASH.) Dr. Harris will also participate on a panel discussion on NASH treatments. The presentations will take place at the 4thAnnual NASH Summit 2020 Digital Conference, which is being held December 15-18, 2020.Details for the oral presentation are as follows:Details for the panel discussion are as follows:A copy of Dr. Harris’ presentation and poster will be accessible on the Events section of the Altimmune website.About the 4thAnnual NASH Summit 2020 Digital ConferenceThe digital...

København Ø, Dec. 11, 2020 (GLOBE NEWSWIRE) —De forventede udbyttesatser for regnskabsåret 2020 for Investeringsforeningen Stonehenge er  foreløbigt beregnet til nedenfor anførte tal udtrykt i kroner pr. bevis.Det understreges, at de anførte tal for 2020 alene er foreløbige og således kan ændre sig, indtil det endelige regnskab foreligger, og udbytterne er vedtaget på foreningens ordinære generalforsamling.Udbytterne forventes udbetalt aconto i februar 2021, således at de vil fragå indre værdi den 9. februar 2021 med valør den 11. februar 2021.Med venlig hilsenBI Management A/S

RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2020 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the JMP Securities Hematology Summit, which is being conducted as a virtual event, on Tuesday, December 15, 2020 at 3:30 p.m. ET.Links to a live audio webcast and replay of the presentation may be accessed in the Investors section of BioCryst’s website at http://www.biocryst.com.About BioCryst PharmaceuticalsBioCryst Pharmaceuticals discovers novel, oral, small-molecule medicines that treat rare diseases in which significant unmet medical needs exist and an enzyme plays a key role in the biological pathway of the disease. Oral, once-daily ORLADEYO™ (berotralstat) is approved in the United States for the prevention of HAE attacks in adults and pediatric patients 12 years and...

TORONTO, Dec. 11, 2020 (GLOBE NEWSWIRE) — Cardinal Resources Limited (ASX/TSX: CDV) (“Cardinal” or “Company”) advises that 16,000,000 unlisted options exercisable at $0.50 per share have been exercised in the Company to raise AU$8.0 million.Attached to this release is the Company’s Appendix 2A – Application for Quotation of Securities and the Appendix 3Y ‐ Change of Director’s Interest Notice for each of the relevant Directors.Authorised for release by the Board of Cardinal Resources Limited.For further information contact:Cannings Purple (Investor Relations, Australia)Peta Baldwin or Warrick HazeldineE: pbaldwin@canningspurple.com.auE: whazeldine@canningspurple.com.auDisclaimerCardinal confirms that it is not aware of any new information or data that materially affects the information included in its announcement of the Ore Reserve...